Bioreactor– tag –
-
Catalent Secures $4.1B Refinancing, Fuels Major Expansion in Biologics and Oral Drug Manufacturing to Meet GLP-1 Demand
Pharmaceutical Technology USA Overview Catalent successfully completed a $4.1 billion debt refinancing, earmarking substantial capital for expanding its biologics and oral drug manufacturing capacity. These strategic investments, includi... -
Allogeneic Cell Therapy Manufacturing: Challenges, Advantages, and the Key Role of Automated Bioreactors for Scalability
sdg.azte.co Global Overview This article delves into the complexities of allogeneic cell therapy manufacturing, highlighting its advantages such as scalability, off-the-shelf availability, and cost-effectiveness. The manufacturing proces... -
Indian Pharma Accelerates Digital Bioprocessing Adoption: Digital Twins Optimize Bioreactor Performance and Mitigate Scale-Up Risks
BioSpectrum India India Overview Indian pharmaceutical companies are accelerating the adoption of digital bioprocessing tools, with a significant focus on digital twin technology to optimize manufacturing. Digital twins accurately simula... -
AI and Digital Twins Accelerate Cultivated Meat Commercialization: Bioprocess Optimization Drives Cost Reduction and Productivity
Food Engineering USA Overview A hybrid model digital twin strategy, combining AI with mechanistic bioprocess modeling, is emerging as an indispensable tool for commercially scaling cultivated meat production. These virtual models optimiz... -
CDMOs Overcome Multispecific Manufacturing Challenges with Continuous Bioprocessing and Catalent’s GPEx® Lightning Platform
BioSpace Unknown Overview Contract Development and Manufacturing Organizations (CDMOs) confront complex challenges in cell line development, analytical characterization, and downstream purification for multispecific molecules. To overcom... -
Modular Bioprocessing Future: Digital Twins and AI Revolutionize Manufacturing, Drastically Reducing Downtime
Industry Publication Unknown Overview Modular bioprocessing is evolving with digital control and AI, significantly boosting efficiency and reliability in biopharmaceutical manufacturing. Digital twin technology is key, enabling predictiv... -
The Bioreactor Scaling Conundrum: Navigating Flexibility, Yield, and Design Trade-offs in Biopharmaceutical Manufacturing
Nature Partnerships International Overview Scaling bioprocess production in bioreactors presents a formidable challenge, characterized by inherent trade-offs between flexibility, cell yield, and process design. Bioreactor specifications ... -
Functional Polymer FP003B Maximizes Cell Yield in Microcarrier MSC Culture by Suppressing Aggregation, Frontiers Reports Breakthrough
Frontiers Switzerland Overview A new study in Frontiers proposes a breakthrough method using functional polymer 003B (FP003B) to significantly inhibit excessive aggregation of microcarriers/mesenchymal stromal cells (MSCs) and enhance ce... -
Small-Scale Bioreactors Market Sees Robust Growth Driven by Innovation; Culture Biosciences and Cytiva Bioscience Partnership Advances Automation
openPR.com International Overview This article provides an overview of a market research report introduced by openPR.com, highlighting significant growth in the small-scale bioreactors market, driven by innovations in bioprocessing effic... -
REPROCELL Accelerates Clinical-Grade iPSC Manufacturing Scale-Up with StemRNA™ Clinical Platform and AI-Driven StemEdit
REPROCELL Japan Overview REPROCELL is significantly accelerating the scale-up of clinical-grade induced pluripotent stem cell (iPSC) manufacturing by leveraging its proprietary StemRNA™ Clinical iPSC platform and AI-driven StemEdit gene-...
